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AMC, University of Amsterdam, Department of Radiology, Meibergdreef 9, NL 1105 AZ Amsterdam-Zuidoost, NetherlandsThe ﬁrst paper on this topic was published in 2006 by Dr
Zamboni, an Italian vascular surgeon, and was titled: ‘The big idea:
iron-dependent inﬂammation in venous disease and proposed paral-
lels in multiple sclerosis’.1 It was not picked up, probably because it
was published in a dubious e-journal with the prestigious name:
‘The Royal Society of Medicine’.
The debate about CCSVI really started in 2009, when Dr Zam-
boni published two studies investigating 109 patients with clini-
cally deﬁnite MS and 177 control subjects with transcranial and
extracranial color duplex examinations. He found that all of the MS
patients had cerebral outﬂow obstructions, while none of the
control patients did. However, these cerebral venous outﬂow
obstructions could only be deﬁned using new criteria, called the
Zamboni criteria. He called his ﬁnding ‘chronic cerebrospinal
venous insufﬁciency’ (CCSVI), and he also claimed a direct relation
with MS.2 In his latest study, published in this issue of the Journal,
he expands on this now calling it the CCSVI syndrome.3 This is not
just semantics, it is (as I will come back to later) a clever PR strategy,
just moving with small steps to increase territory. A syndrome is
more than a ﬁnding. It is any combination of signs and symptoms
that are indicative of a particular disease or disorder. So by calling it
a syndrome, CCSVI is now indicative of MS. The next claim Dr
Zamboni brought forward was that venoplasty of these supposed
venous obstructions could cure patients or at least improve their
MS complaints.
The main questions discussed in recent years are: (i) Does CCSVI
exist? and (ii) Is there a relationship with MS? The science
produced by Dr Zamboni et al. has recently been scrutinized in two
excellent papers. Dr Bagert has evaluated the scientiﬁc value of the
available data, while Dr D’Haeseleer has checked the validity of the
Zamboni hypothesis concerning cerebral hypoperfusion and iron
deposits and its relationship with MS.4,5 The Zamboni science, both
for the existence of CCSVI and a cure after venoplasty, is full of
methodological ﬂaws and does not stand up to close scientiﬁc
scrutiny. The hypothesis behind CCSVI and MS is based on an
erroneous interpretation of well-known facts about MS. Cerebral
hypoperfusion is a recognised phenomenon in MS and is due to
decreased arterial inﬂow, while iron deposits have no relationship
with MS. End of story, however..
The expansion of CCSVI seems not to be inﬂuenced by any
scientiﬁc rationale as we know it. On the contrary, it is booming and* Tel.: þ31 20 566 3228; fax: þ31 20 566 9119.
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ment all over the world for large fees. Some interventionists take
the standpoint that you should offer this treatment because
patients want it, and it would be otherwise unethical not to treat.
Conversely, others say that you should only treat patients in a well-
designed trial.6 I think in this day and age patients should rightfully
demand clear information from their doctor about any proposed
treatment. In that respect, what could you honestly say to a patient
should he/she ask you about the proven value, long-term outcome
and risks of this treatment?
But the most striking aspect regarding the spread of CCSVI
treatment is the very clever and unprecedented PR strategy. Calling
it the “liberation treatment” is only one aspect of this. I have talked
to several doctors who perform the treatment and I have always
had the strong feeling that I was talking to converts. I get personal
e-mails telling me that I should meet Dr Zamboni because he is
such a nice and gentle person. I have only seen him once at
a meeting where his hypothesis, results and ethics were very
heavily attacked, but this seemed only to contribute to his
charisma: ie that of the underdog who is denied fame for his Big
Idea. He appears on television all over the world, you can see him
on the internet, he is invited to every scientiﬁc meeting because he
is hot news. You can see hundreds of patients testifying on the
internet how their MS has been cured by his treatment. Sadly, any
discussion about the evidence is no longer academic, but is now
mainly taking place on internet blogs and in the media. Academic
arguments about the quality of the evidence are viewed as irrele-
vant or arrogant. This is not evidence-based science but Internet-
based practice. To me it brings up the image of a sect where there
is no longer a place for rational thinking.
The paper published in this issue of the EJVES is of very poor
design and includes only 15 patients. It bears no resemblance to
anything remotely connected to a randomised trial.3 Nevertheless,
the online version of this paper has already been sent to me as the
ultimate proof that I am wrong in my denial of CCSVI. In my
opinion, every positive paper in a Journal (irrespective of the
quality) and every faculty invitation are just new bricks for the
house of CCSVI.
There is only one way out, and that is to perform a double-
blinded randomised trial with a sham arm. But having talked to
serious neurologists I know that this would be very difﬁcult to do,
because they rightly believe that this would be unethical, based on
the poor evidence available to us. It is a classic ‘Catch-220 situation
and desperate MS patients and their families will continue to paySociety for Vascular Surgery.
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science.’
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